Skip to main content

Table 1 Baseline characteristics

From: ICT-based adherence monitoring in kidney transplant recipients: a randomized controlled trial

  Intervention (n = 51) Control (n = 54)
Age, years 49.9 ± 10.0 49.0 ± 12.2
Male, n (%) 31 (60. 8) 29 (53.7)
Smoking, n (%)
 Non-smoker 39 (76.5) 48 (88.9)
 Ex-smoker 8 (15.7) 6 (11.1)
 Current smoker 4 (7.8) 0 (0)
Time after KT, months 30.7 ± 19.8 15.7 ± 9.5
Primary renal disease, n (%)
 Diabetes 13 (25.5) 13 (24.1)
 Non-diabetes 38 (74.5) 41 (75.9)
Donor age, years 46.0 ± 12.6 45.3 ± 14.8
Donor male, n (%) 25 (49.0) 31 (59.6)
Donor type, n (%)
 Living 24 (47.1) 19 (35.2)
 Deceased 27 (52.9) 35 (64.8)
Number of HLA mismatch
 Total 3.5 ± 1.9 3.0 ± 1.6
 DR 1.1 ± 0.8 1.0 ± 0.6
PRA > 10%, n (%) 11 (21.6) 13 (24.1)
Baseline laboratory data
 Creatinine, mg/dL 1.1 ± 0.4 1.1 ± 0.3
 eGFR, mL/min/1.73 m2 69.7 ± 19.0 74.3 ± 22.2
  1. Values are shown as mean ± standard deviation or number (%)
  2. eGFR estimated glomerular filtration rate, HLA Human leukocyte antigen, KT Kidney transplantation, PRA Panel-reactive antibody